A staggering 1 in 7 women suffer from perinatal mood disorders, which can begin as early as pregnancy. We take a look at how these scientists are working to find ways to help halt depression in moms at the most critical juncture: before it starts.
From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
From breakthrough work to eradicate some of the world's deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.
Imagine being depressed and trying medication after medication—only to find none work. That's the plight of people with treatment-resistant depression. We look at this little-understood condition, and how researchers are working to crack its code.
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson's Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.
It's a complicated illness, with no exact cause—but there is still a lot we understand now about depression, thanks to the work of dedicated scientists. For Depression Awareness Month, we look at the facts, common misconceptions and research that's underway.
Husseini Manji, M.D., is working toward a world in which diseases like depression and schizophrenia are diagnosed quickly and handled without stigma. His team's discoveries in the lab may just get us there.